Product Comparison
![]() |
![]() |
![]() |
![]() |
![]() |
|
---|---|---|---|---|---|
McKesson # | 1184166 | 570758 | 1205509 | 1057134 | 495294 |
Description | Ciprofloxacin HCl 500 mg Tablet Bottle 100 Tablets | Ciprofloxacin HCl 0.3% Drops Bottle 5 mL | Ciprofloxacin HCl 500 mg Tablet Bottle 500 Tablets | Levofloxacin 500 mg Tablet Bottle 50 Tablets | Ciprofloxacin HCl 0.3% Drops Bottle 2.5 mL |
Manufacturer # | 58657067601 | 61314065605 | 65862007705 | 31722072250 | 61314065625 |
Brand | |||||
Manufacturer | Method Pharmaceuticals | Sandoz | Aurobindo Pharma | Camber Pharmaceutical | Sandoz |
Invoice | CIPROFLOXACIN, TAB 500MG (100/BT) | CIPROFLOXACIN, DRP OPHTH 0.3% 5ML | CIPROFLOXACIN HCL, TAB 500MG (500/BT) | LEVOFLOXACIN, TAB 500MG (50/BT) | CIPROFLOXACIN, DRP OPHTH 0.3% 2.5ML |
Log In to Order | Log In to Order | Log In to Order | Log In to Order | Log In to Order | |
Comparison |
|||||
Alternate Manufacturer Number | 1571926 | 1266089 | 2361855 | 1265883 | |
Country of Origin | Unknown | Unknown | Unknown | India | Unknown |
Dosage Form | Tablet | Drops | Tablet | Tablet | Drops |
Generic Drug Code | 47051 | 33580 | 47074 | 33580 | |
Generic Drug Name | Ciprofloxacin HCl | Ciprofloxacin HCl | Ciprofloxacin HCl | Levofloxacin | Ciprofloxacin HCl |
NDC Number | 58657067601 | 61314065605 | 65862007705 | 31722072250 | 61314065625 |
Quantity | 100 Tablets | 500 Tablets | 50 Tablets | ||
Strength | 500 mg | 0.3% | 500 mg | 500 mg | 0.3% |
Type | Ophthalmic | Ophthalmic | |||
UNSPSC Code | 51282909 | 51282909 | 51282909 | 51282926 | 51282909 |
Volume | 5 mL | 2.5 mL | |||
Application | Quinolone | Quinolone | Quinolone | Quinolone | Quinolone |
Container Type | Bottle | Bottle | Bottle | Bottle | Bottle |
Product Dating | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Features and Benefits |
|
|
|
|
|